Expectations and Side Effects of Endocrine Therapy in Women With Breast Cancer
|ClinicalTrials.gov Identifier: NCT02088710|
Recruitment Status : Active, not recruiting
First Posted : March 17, 2014
Last Update Posted : September 26, 2017
Philipps University Marburg Medical Center
Information provided by (Responsible Party):
Yvonne Nestoriuc, PhD., Philipps University Marburg Medical Center
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Active, not recruiting|
|Actual Primary Completion Date :||December 2012|
|Estimated Study Completion Date :||February 2020|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Pan Y, Heisig SR, von Blanckenburg P, Albert US, Hadji P, Rief W, Nestoriuc Y. Facilitating adherence to endocrine therapy in breast cancer: stability and predictive power of treatment expectations in a 2-year prospective study. Breast Cancer Res Treat. 2018 Apr;168(3):667-677. doi: 10.1007/s10549-017-4637-2. Epub 2018 Jan 12.
Nestoriuc Y, von Blanckenburg P, Schuricht F, Barsky AJ, Hadji P, Albert US, Rief W. Is it best to expect the worst? Influence of patients' side-effect expectations on endocrine treatment outcome in a 2-year prospective clinical cohort study. Ann Oncol. 2016 Oct;27(10):1909-15. doi: 10.1093/annonc/mdw266. Epub 2016 Aug 22.